John Imig

Dr. Imig joined the Medical College of Wisconsin in 2008 and is currently Professor and Director of the Drug Discovery Center in the Department of Pharmacology & Toxicology. Dr. Imig has dedicated his research and drug development efforts to understanding the mechanisms by which certain fatty acids “eicosanoids” influence kidney and cardiovascular function and developing drugs that target eicosanoids to treat diseases. As an academic research scientist, Dr. Imig has authored over 200 scientific publications and has several patents for eicosanoid-based drugs. He is a past recipient of the prestigious Established Investigator Award from the American Heart Association and the laboratory is currently funded by a grant from the National Institutes of Health and a Falk Medical Trust Grant. He has successfully worked with pharmaceutical and biotechnology companies through research and licensing agreements to move drugs forward into clinical trials. Over the past decade, he and his collaborators have developed novel eicosanoid-based drugs to treat diseases including hypertension, stroke, heart attacks, diabetes, and kidney diseases. These novel drugs have tremendous potential as a therapy for cardiovascular and kidney diseases.